CRDF: Cardiff Oncology, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-27 | Fell below 5% | BlackRock, Inc. | 1.30% | SEC |
Institutional ownership (Q2 2026)
104 institutions reported holding $23.37M of Cardiff Oncology, Inc. on Form 13F (117 the quarter before). 20 opened a new position and 31 sold out. Shares held by institutions: -24%.
| Largest holders | Shares | Value |
|---|---|---|
| Laurion Capital Management LP | 3,098,299 | $4.03M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,895,592 | $3.76M |
| Pfizer Inc | 2,411,575 | $3.01M |
| FRANKLIN RESOURCES INC | 1,205,803 | $1.57M |
| BlackRock, Inc. | 972,873 | $1.26M |
| BLAIR WILLIAM & CO/IL | 912,513 | $1.19M |
| GEODE CAPITAL MANAGEMENT, LLC | 820,062 | $1.07M |
| UBS Group AG | 638,699 | $830K |
| JANE STREET GROUP, LLC | 607,900 | $790K |
| VANGUARD FIDUCIARY TRUST CO | 410,602 | $534K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.